Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1753-6561
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors ; volume:7 ; number:2 ; day:4 ; month:4 ; year:2013 ; pages:1 ; date:4.2013
BMC proceedings / Biomed Central; 7, Heft 2 (4.4.2013), 1, 4.2013
- Urheber
-
Mello, Barbara P.
de Carvalho, Daniel D.
Campos, Antonio HJFM
Soares, Fernando A.
Amarante-Mendes, Gustavo P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1753-6561-7-S2-P10
- URN
-
urn:nbn:de:101:1-2021082909390845538279
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mello, Barbara P.
- de Carvalho, Daniel D.
- Campos, Antonio HJFM
- Soares, Fernando A.
- Amarante-Mendes, Gustavo P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
EZH2: novel therapeutic target for human cancer
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
EZH2: a novel target for cancer treatment
Integrins regulate stemness in solid tumor: an emerging therapeutic target
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
The potential of PARP as a therapeutic target across pediatric solid malignancies
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Symmetric solid target transport system
A honeycomb solid target design
EZH2: novel therapeutic target for human cancer
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
EZH2: a novel target for cancer treatment
Integrins regulate stemness in solid tumor: an emerging therapeutic target
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
The potential of PARP as a therapeutic target across pediatric solid malignancies
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Symmetric solid target transport system
A honeycomb solid target design
EZH2: novel therapeutic target for human cancer
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
EZH2: a novel target for cancer treatment
Integrins regulate stemness in solid tumor: an emerging therapeutic target
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
The potential of PARP as a therapeutic target across pediatric solid malignancies
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Symmetric solid target transport system